EFDID: 490880EFD: View Filing

Issuer: Petros Pharmaceuticals, Inc. (0001815903) - D

Accession: 0001104659-23-083066 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001815903
  • Entity Name:
    Petros Pharmaceuticals, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2020)
  • Address:
    1185 AVENUE OF THE AMERICAS
    3RD FLOOR
    NEW YORK, NY 10036
  • Persons:
    Related Persons 7
    Mitchell Arnold
    Executive Officer 
    Vice President of Finance and Principal Accounting Officer
    Fady Boctor
    Executive Officer 
    President and Chief Commercial Officer
    John D. Shulman
    Director
    Joshua N. Silverman
    Director
    Bruce T. Bernstein
    Director
    Gregory Bradley
    Director
    Wayne R. Walker
    Director
EDGAR: Offering Information
  • Accession Date:
    07/21/2023
  • First Sale Date:
    07/13/2023
  • Offering Amount:
    $30,000,006
  • Amount Sold:
    $30,000,006
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
  • Sales Clarification:
    Includes aggregate exercise price of warrants of $2.25 (subject to price-based adjustment), that may be received upon exercise of the warrants
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:CT, NJ, NY
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Katalyst Securities LLC 112494 None None CT, FL, NJ, NY
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Petros Pharmaceuticals, Inc./s/ Fady BoctorFady BoctorPresident and Chief Commercial Officer2023-07-21